Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cell Communication and Signaling : CCS|October 29, 2020
LncRNAH19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1Weiwei Gui, Wei Fen Zhu, Yiyi Zhu, et al.
Cells|October 27, 2022
Biomarker-Targeted Therapies in Non-Small Cell Lung Cancer: Current Status and PerspectivesHaiyang Guo, Jun Zhang, Chao Qin, et al.
Discover Oncology|June 6, 2026
GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinomaZixu Wang, Jiang Fu, Shengjie Tang, et al.
Cells|February 15, 2022
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and ProspectsShengjie Tang, Chao Qin, Haiyang Hu, et al.
Optics Express|November 22, 2024
Computing dimension for a reconfigurable photonic tensor processing core based on silicon photonicsHao Ouyang, Zilong Tao, Jie You, et al.
Frontiers in Pharmacology|November 17, 2022
miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potentialHang Yan, Shengjie Tang, Shoujun Tang, et al.
Frontiers in Oncology|May 11, 2026
Advances in neurotensin receptor 1-targeted molecular probes for tumor molecular imaging and therapyChengkuan Liu, Jiang Fu, Shengjie Tang, et al.
Frontiers in Oncology|June 24, 2026
The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranosticsYunLong Yang, Jiang Fu, ShengJie Tang, et al.
Scientific Reports|November 7, 2023
Development and validation of a prognostic model of survival for classic heatstroke patients: a multicenter studyYu Wang, Donglin Li, Zongqian Wu, et al.
Frontiers in Oncology|April 29, 2026
Radionuclide theranostics: advances and clinical applications in lung cancerYang Yang, Jiang Fu, ShengJie Tang, et al.
Pageof 4